Primary & secondary use of EHR systems workshop 11 & 12 October 2007 1 Focus on safety Tim Buxton Head of Sector, Project Management EMEA.

Slides:



Advertisements
Similar presentations
Overview of Risk management: A EU perspective Lincoln Tsang May 2008.
Advertisements

6th European Patients’ Rights Day The EMA Geriatric Medicines Strategy and the empowered aging patient Francesca Cerreta EMA (European Medicines Agency)
UKCPRS Drug Dictionary Project Update for HL7 Autumn 2002 Julie James/Paul Frosdick Blue Wave Informatics / NHS Information Authority.
Aspects of DICOM for Patient Safety
HL7 Activities with other SDOs 16 May 2010
Joint TC Meeting: EHR – RCRIM RCRIM Overview HL7 Working Group Meeting January, 2007 Presented by: Ed Tripp Program Director, eSubmissions Abbott (RCRIM.
17 September 2007ISO TC215 WG6 Brisbane1 Identification of Medicinal Products & Pharmacovigilance Task Forces.
EHR stakeholder workshop – 11th October EHR integration for clinical research: toward new interaction models ? Isabelle de Zegher.
© Safeguarding public health Expert Group on Innovation in the Regulation of Healthcare products Adaptive Licencing workshop at the Wellcome Trust October.
Disclaimer The presentation is intended for educational purposes only and does not replace independent professional judgement. Statements of fact and opinions.
Overview of Computers and Nursing
WG 6 «Pharmacy & Medication» Current activities Porto, Wednesday 11th June 2014.
© Teva Pharmaceuticals Europe 02 October 2007 Pharmacovigilance and electronic reporting Background and procedures Wendy Huisman EU QP Teva Pharmaceuticals.
Slide 1 November 2008 Name Sarah Morgan © Crown copyright 2005 Pharmacovigilance Working Party - Role and future perspective Sarah Morgan Medicines and.
HIMMA National Conference 2005 Accelerating E-Health Dr Ian Reinecke CEO National E-Health Transition Authority (NEHTA) Geelong 29 July 2005 nehta.
Meldingen 30 november 2011 Anja van Haren EudraVigilance Coördinator Informatiebijeenkomst nieuwe wetgeving farmacovigilantie.
Overview of Computers and Nursing Virginia K. Saba Kathleen A. McCormick.
New ISO projects Joint meeting HL7, IHE and ISO Pharmacy groups Leonora Grandia, Z-Index.
PHC Meeting the global challenge of unique identification of medicinal products Overview of objectives, outcomes and process Contact:
 Pharmacovigilance – Patient’s standpoint Steve Arlington May 2007.
HL7 Medication and UKCPRS Julie James Partner Blue Wave Informatics.
Benefits of a strong collaboration with patient groups at national and EU level Susanna Palkonen, Director European Federation.
Pharmacovigilance obligations of the Pharmaceutical companies in India
Nadja Jastrebova Pharmacovigilance Consulting Global Services Section
Pharmacovigilance Programme of India
MINISTRY OF HEALTH REPUBLIC OF LITHUANIA Can new Member States leap-frog the eHealth revolution? Mrs. Vita Sinicienė Head of Information technology Division.
Medication Documentation Challenges and first impressions José Costa Teixeira October 2014.
National Competent Authorities in Member States
E in pharmacy Gatis Ozoliņš Head of Information Department State Agency of Medicines, Latvia Baltic IT&T 2005 Forum: eBaltics Rīga, 08 April 2005.
Networking and Health Information Exchange Unit 7d Supporting Standards for EHR Application.
Regulators’ response to consultation on EU legislative proposals for pharmacovigilance : common themes 2 nd International Pharmaceutical Regulatory and.
Health IT Workforce Curriculum Version 1.0 Fall Networking and Health Information Exchange Unit 3b National and International Standards Developing.
EHR stakeholder workshop – 11th October EHR integration for clinical research: Legal & Privacy issues Mats Sundgren – AstraZeneca Petra Wilson -
Patient safety and pharmacovigilance: the role of Community pharmacists Flora Giorgio-Gerlach Secretary General PGEU.
About OMICS Group OMICS Group is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in.
Barcode Technology in healthcare Nowadays, published reports illustrate high rates of medical error (adverse events) and the increasing costs of healthcare.
Topic 3A SEMANTIC INTEROPERABILITY: REUSE OF EHR DATA Mats Sundgren.
1 CDISC HL7 Project FDA Perspective Armando Oliva, M.D. Office of Critical Path Programs FDA.
An agency of the European Union Presented by: Noël Wathion Head of Unit, Patient Health Protection HMA – Human Agenda item 3: Implementation of the New.
Federal Medication Terminologies (FMT) Enabling Health IT Interoperability.
When Supply Chain meets Care Delivery: Background on GS1 and HL7 Ulrike Kreysa Director Healthcare, GS1 Global Office.
TAIEX Workshop on the Implementation of EU Pharmacovigilance Legislation - BELGRADE CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser.
‘Implementation of SNOMED CT ’ Oct’ 2012 Denise Downs, Implementation & Engagement Lead.
Informatics for Scientific Data Bio-informatics and Medical Informatics Week 9 Lecture notes INF 380E: Perspectives on Information.
Agencija za lekove i medicinska sredstva Srbije Pharmacovigilance System in Serbia: Current Status and Challenges Jović Ivana, M. Pharm. Medicines and.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
IDMP Overview December 2015.
All Hands Electronic Information Integrity Call White Paper An Introduction to the Current State of EMR – et.al. R. L. Chamberlain, Ph.D.
Introduction to Health Policy and Law Jody Blanke Distinguished Professor of Computer Information Systems and Law Mercer University.
Chapter 15 by Emily B. Barey The Electronic Health Record and Clinical Informatics.
Training Manual for MAH ElViS (Electronic Vigilance System)
Social Pharmacy and Pharmacovigilance
Efficacy and Safety of Medicines
Information on Medicinal Products
FHIR Adverse Event Resource
EudraVigilance.
Plan of activities on e-health development for years
WP1: D 1.3 Standards Framework Status June 25, 2015
INTRODUCTION The oral route of drugs administration is the most important method of administering drugs for systemic effects.
Impact of Informatics on Today’s Healthcare System
13 September 2018 PHPID and its enabler role for identification of medicines for e-prescription Towards a trans-atlantic solution to univocally identify.
Helen Lee, European Commission
The importance of dialogue between regulators
Innovative Medicines Initiative:
California’s “Comprehensive Compliance Program” Law
Commission strategy to
The Stakeholder’s perspective in Pharmacy Education
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Prudent Healthcare Prescribing Workshop April 2014
Saudi Arabia: Veterinary Pharmaceutical Legislations &
Presentation transcript:

Primary & secondary use of EHR systems workshop 11 & 12 October Focus on safety Tim Buxton Head of Sector, Project Management EMEA

Primary & secondary use of EHR systems workshop 11 & 12 October Introduction Basis of the presentation –Contribution to the discussion; not a position statement –High level, abstracted perspective Today –EudraVigilance –E2B –ISO work items: Pharmacovigilance and identification of medicinal products Interaction model –Stakeholders –Issues

Primary & secondary use of EHR systems workshop 11 & 12 October EudraVigilance E2B Message Gateway EVMPD Post CT Vet EudraVigilance Warehouse Business Intelligence ………………… Eudra- Vigilance DAS ICSR (H) ICSR (V) SUSAR

Primary & secondary use of EHR systems workshop 11 & 12 October N 547 Health informatics Identification of medicinal products Data elements and structures for the exchange of regulated product information for drug dictionaries N548 Health informatics Identification of medicinal products Structures and controlled vocabularies for pharmaceutical product identifiers (PhPIDs) N549 Health informatics Identification of medicinal products Structures and controlled vocabulary for ingredients N549 Health informatics Identification of medicinal products Structures and controlled vocabulary for ingredients N551 Health informatics Identification of medicinal products Structures and controlled vocabulary for units of measurement N551 Health informatics Identification of medicinal products Structures and controlled vocabulary for units of measurement N550 Health informatics Identification of medicinal products Structures and controlled vocabulary for units of presentation N550 Health informatics Identification of medicinal products Structures and controlled vocabulary for units of presentation N550 Health informatics Identification of medicinal products Structures and controlled vocabulary for pharmaceutical dose forms N550 Health informatics Identification of medicinal products Structures and controlled vocabulary for pharmaceutical dose forms N550 Health informatics Identification of medicinal products Structures and controlled vocabulary for routes of administration N550 Health informatics Identification of medicinal products Structures and controlled vocabulary for routes of administration N546 Health informatics Pharmacovigilance Structures and controlled vocabulary for laboratory test units for the reporting of laboratory results N546 Health informatics Pharmacovigilance Structures and controlled vocabulary for laboratory test units for the reporting of laboratory results N545 Health informatics Pharmacovigilance Individual case safety report

Primary & secondary use of EHR systems workshop 11 & 12 October An interaction model? ADR SUSAR E2B Message Signal Action Stakeholders: Patients Healthcare professionals Pharma companies Regulators IT vendors Data vendors PSUR

Primary & secondary use of EHR systems workshop 11 & 12 October Issues Reporting compliance Quality of data Consistency of data Availability of data